3-deoxyglycero-galacto-nonulosonic acid

deaminated neuraminic acid from rainbow trout; structure given in first source

Also Known As:

2-KDN; 2-keto-3-deoxy-D-glycero-D-galacto-nononic acid; 2-oxo-3-deoxy-D-glycero-galactononulosonic acid; 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid; 3-deoxyglycerogalacto-2-nonulopyranosonic acid; deoxy-KDN; siaX; sialosonic acid; D-glycero-D-galacto-2-nonulosonic acid, 3-deoxy-

Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Hirai, Go: 1 article (12/2020)
2.	Honda, Akinobu: 1 article (12/2020)
3.	Minoda, Masaya: 1 article (12/2020)
4.	Shiozaki, Kazuhiro: 1 article (12/2020)
5.	Uezono, Keiya: 1 article (12/2020)
6.	Wakata, Ryuta: 1 article (12/2020)
7.	Holzmann, Martin J: 1 article (01/2016)
8.	Olsson, Daniel P: 1 article (01/2016)
9.	Sartipy, Ulrik: 1 article (01/2016)
10.	Troy, Frederic A: 1 article (12/2015)

Related Diseases

1.	Wounds and Injuries (Trauma) 07/01/1991 - "The study shows that a consistent therapy performed with dry wound dressings such as SIAX is superior to the conventional topical therapy of venous leg ulcers in some cases. " 07/01/1991 - "In a controlled randomized study on 40 patients with venous leg ulcers, monotherapy with a dry wound dressing (silver-impregnated--activated charcoal xerodressing; SIAX) was tested. "
2.	Leg Ulcer 07/01/1991 - "The study shows that a consistent therapy performed with dry wound dressings such as SIAX is superior to the conventional topical therapy of venous leg ulcers in some cases. " 07/01/1991 - "In a controlled randomized study on 40 patients with venous leg ulcers, monotherapy with a dry wound dressing (silver-impregnated--activated charcoal xerodressing; SIAX) was tested. "
3.	Ulcer 07/01/1991 - "In addition, the ulcers of 6/19 patients (= 31.6%) treated with SIAX healed completely within the study period, in contrast to only 2/19 patients (= 10.5%) receiving conventional therapy. " 07/01/1991 - "In the statistical comparison of SIAX therapy (n = 19) and conventional therapy (n = 19) significant differences were found in favour of the SIAX group (increase of epithelialization, reduction of ulcer size; P less than 0.05). "
4.	Neoplasms (Cancer) 12/01/2020 - "2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) is a minor component of sialic acids detected in vertebrates, such as human cancer cells, rat liver, and fish tissues. " 08/26/1994 - "The release of 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN, deaminoneuraminic acid) residues from their alpha-ketosidic linkage is required to determine the structural and functional role of KDN-glycoconjugates in sources as disparate as trout egg polysialoglycoproteins and human cancers. "
5.	Carcinogenesis 08/01/2001 - "2-keto-3-deoxy-D-glycero-D-galacto-nononic acid (KDN) is a sialic acid (Sia) that is ubiquitously expressed in vertebrates during normal development and tumorigenesis. "

Related Drugs and Biologics

1.	Silver
2.	Charcoal (Charbon)
3.	N-Acetylneuraminic Acid (Sialic Acid)
4.	Teicoplanin
5.	Sialoglycoproteins
6.	Sialic Acids
7.	Glycoconjugates
8.	Antigens
9.	Acids

Related Therapies and Procedures

1.	Therapeutics